Oxalic Acid

Oxalic Acid

SCHEMBL9613762

CN(C)C(CCOc1cccc2ccccc12)c1ccccc1C(F)(F)F.O=C(O)C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.47
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 5/20 0.45
HPGD P15428 3/20 0.45
ATM Q13315 1/20 0.45
HTR1B P28222 5/20 0.43
TDP1 Q9NUW8 1/20 0.41
HTR1D P28221 2/20 0.41
MCL1 Q07820 2/20 0.41
RBP4 P02753 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9613845 0.86 KMT2A (0.50) SLC6A4KMT2AKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL9613942 0.86 SLC6A4 (0.49) SLC6A4KMT2AKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL9614126 0.85 KMT2A (0.49) SLC6A4KMT2AKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL9613944 0.84 KMT2A (0.48) KMT2AKDM4EALDH1A1HPGDATM
Oxalic Acid SCHEMBL9613860 0.83 KMT2A (0.48) SLC6A4KMT2AKDM4EALDH1A1HPGD
Dapoxetine SCHEMBL9614075 0.82 KMT2A (0.59) KMT2AKDM4EALDH1A1HPGDATM
Oxalic Acid SCHEMBL9613984 0.81 KMT2A (0.52) SLC6A4KMT2AKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL9613810 0.78 KMT2A (0.52) SLC6A4KMT2AKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL9613796 0.78 KMT2A (0.51) SLC6A4KMT2AKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL9613788 0.78 CHRNB2 (0.48) KMT2AKDM4EALDH1A1MCL1RBP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135947-A Treatment of depression, eating disorders, and alcoholism ELI LILLY AND COMPANY (US) 1992-08-04 US disclosed
EP-0288188-B1 1-PHENYL-3-NAPHTHALENYLOXY-PROPANAMINES ELI LILLY AND COMPANY (US) 1991-10-16 EP disclosed